263 related articles for article (PubMed ID: 27716849)
21. In vivo and in vitro regulation of type I IFN synthesis by synergistic effects of CD40 and type II IFN.
Greene JA; DeVecchio JL; Gould MP; Auletta JJ; Heinzel FP
J Immunol; 2006 May; 176(10):5995-6003. PubMed ID: 16670308
[TBL] [Abstract][Full Text] [Related]
22. RTP4 inhibits IFN-I response and enhances experimental cerebral malaria and neuropathology.
He X; Ashbrook AW; Du Y; Wu J; Hoffmann HH; Zhang C; Xia L; Peng YC; Tumas KC; Singh BK; Qi CF; Myers TG; Long CA; Liu C; Wang R; Rice CM; Su XZ
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19465-19474. PubMed ID: 32709745
[TBL] [Abstract][Full Text] [Related]
23. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
Qi Z; Han X; Zhang Y; Wang J; Cao YM
Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.
Lacerda-Queiroz N; Riteau N; Eastman RT; Bock KW; Orandle MS; Moore IN; Sher A; Long CA; Jankovic D; Su XZ
Sci Rep; 2017 Sep; 7(1):10438. PubMed ID: 28874800
[TBL] [Abstract][Full Text] [Related]
25. Inflammasome activation negatively regulates MyD88-IRF7 type I IFN signaling and anti-malaria immunity.
Yu X; Du Y; Cai C; Cai B; Zhu M; Xing C; Tan P; Lin M; Wu J; Li J; Wang M; Wang HY; Su XZ; Wang RF
Nat Commun; 2018 Nov; 9(1):4964. PubMed ID: 30470758
[TBL] [Abstract][Full Text] [Related]
26. TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells.
Takashima K; Oshiumi H; Matsumoto M; Seya T
Biochem Biophys Res Commun; 2018 May; 499(4):985-991. PubMed ID: 29627569
[TBL] [Abstract][Full Text] [Related]
27. Scaffolding adaptor protein Gab1 is required for TLR3/4- and RIG-I-mediated production of proinflammatory cytokines and type I IFN in macrophages.
Zheng Y; An H; Yao M; Hou J; Yu Y; Feng G; Cao X
J Immunol; 2010 Jun; 184(11):6447-56. PubMed ID: 20435932
[TBL] [Abstract][Full Text] [Related]
28. Host responses to Plasmodium yoelii hepatic stages: a paradigm in host-parasite interaction.
Lau AO; Sacci JB; Azad AF
J Immunol; 2001 Feb; 166(3):1945-50. PubMed ID: 11160243
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
[TBL] [Abstract][Full Text] [Related]
30. Flt3 ligand treatment modulates parasitemia during infection with rodent malaria parasites via MyD88- and IFN-γ-dependent mechanisms.
Tamura T; Akbari M; Kimura K; Kimura D; Yui K
Parasite Immunol; 2014 Feb; 36(2):87-99. PubMed ID: 24400637
[TBL] [Abstract][Full Text] [Related]
31. Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion.
Wu J; Dobbs N; Yang K; Yan N
Immunity; 2020 Jul; 53(1):115-126.e5. PubMed ID: 32640258
[TBL] [Abstract][Full Text] [Related]
32. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
Kobayashi F; Ishida H; Matsui T; Tsuji M
J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
[TBL] [Abstract][Full Text] [Related]
33. Properties and Roles of γδT Cells in
Xie H; Xie S; Wang M; Wei H; Huang H; Xie A; Li J; Fang C; Shi F; Yang Q; Qi Y; Yin Z; Wang X; Huang J
Front Cell Infect Microbiol; 2021; 11():788546. PubMed ID: 35127555
[TBL] [Abstract][Full Text] [Related]
34. In vivo approaches reveal a key role for DCs in CD4+ T cell activation and parasite clearance during the acute phase of experimental blood-stage malaria.
Borges da Silva H; Fonseca R; Cassado Ados A; Machado de Salles É; de Menezes MN; Langhorne J; Perez KR; Cuccovia IM; Ryffel B; Barreto VM; Marinho CR; Boscardin SB; Álvarez JM; D'Império-Lima MR; Tadokoro CE
PLoS Pathog; 2015 Feb; 11(2):e1004598. PubMed ID: 25658925
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic activities of CD8⁺ T cells collaborate with macrophages to protect against blood-stage murine malaria.
Imai T; Ishida H; Suzue K; Taniguchi T; Okada H; Shimokawa C; Hisaeda H
Elife; 2015 Mar; 4():. PubMed ID: 25760084
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of dendritic cell activation via CD40 ligand-expressing γδ T cells is responsible for protective immunity to Plasmodium parasites.
Inoue S; Niikura M; Takeo S; Mineo S; Kawakami Y; Uchida A; Kamiya S; Kobayashi F
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12129-34. PubMed ID: 22778420
[TBL] [Abstract][Full Text] [Related]
37. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
38. Reduction of conventional dendritic cells during Plasmodium infection is dependent on activation induced cell death by type I and II interferons.
Tamura T; Kimura K; Yui K; Yoshida S
Exp Parasitol; 2015 Dec; 159():127-35. PubMed ID: 26420463
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells from malaria-infected mice are fully functional APC.
Perry JA; Rush A; Wilson RJ; Olver CS; Avery AC
J Immunol; 2004 Jan; 172(1):475-82. PubMed ID: 14688357
[TBL] [Abstract][Full Text] [Related]
40. Immune responses mediating survival of naive BALB/c mice experimentally infected with lethal rodent malaria parasite, Plasmodium yoelii nigeriensis.
Singh B; Nayak BP; Rao KV; Sharma P
Microbes Infect; 2000 Apr; 2(5):473-80. PubMed ID: 10865192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
